Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.13 by 7.69 percent. This is unchanged from the same period last year. The company reported quarterly sales of $69.731 million which beat the analyst consensus estimate of $67.098 million by 3.92 percent. This is a 23.06 percent increase over sales of $56.662 million the same period last year.